Feasibility of renal transplantation in patients older than 55 years


A.V. Vatazin, E.O. Shherbakova, E.I. Prokopenko, V.A. Stepanov

SBHI of Moscow Area “Moscow Regional Research Clinical Institute n.a. M.F. Vladimirskiy”, Faculty of Advanced Medical Studies, Department of Transplantology, Nephrology and Artificial Organs
The article discusses the growing number of elderly patients with chronic kidney disease. Renal transplantation is considered to be an effective treatment modality for end-stage kidney disease. The authors provide the analysis of renal transplantation results (2009-2013) in two groups: patients aged 18 to 55 years and those older than 55 years. In conclusions, renal transplantation offers a substantial advantage in elderly patients.

Literature


  1. Hemmelgarn B.R., James M.T., Manns B.J., O'Hare A.M., Muntner P., Ravani P., Quinn R.R., Turin T.C., Tan Z., Tonelli M.; Alberta Kidney Disease Network. Rates of treated and untreated kidney failure in older vs younger adults. JAMA. 2012;307(23):2507–15.
  2. James M.T., Hemmelgarn B.R., Tonelly M. Early recognition and prevention of chronic kidney disease. Lancet. 2010;375(9722):1296–309.
  3. Kurella M., Covinsky K.E., Colins A.K., Chertow G.M. Octogenarians and nonagenarians starting dialysis in the Unated States. Ann. Intern. Med. 2007;146(3):177–83.
  4. Keitz D.S. Transplantation in the elderly patients. Clin. Geriatr. Mtd. 2013;96(6):573–8.
  5. Zhang O.L., Rottenbacher D. Prevalence of chronic kidney disease in population based studies: systematic review. BMC Public Health. 2008;8:117.
  6. Pontictlli C. Should renal transplantation be offered to older patients? NDT. 2000;15(3):315–7.
  7. Opelz G., Dohler B. Cardiovascular Dearth in kidney recipients treated with renin-angiothensin blokers. Am. J. Tranh. 2013;13(8):2096–105.
  8. Wiccelli A. The impact of abnormal glucose regulation on arterial staffness at 3 and 15 monthes after kidney transplantation. Diabetol. Metabol. Syndrom. 2014;6:52.
  9. Lenihan C.R., Hurley M.P., Tan J.C. Comorbiditys and kidney transplant evaluation in the eldtrly. Am. J. Ntphrol. 2013;38(3):204–11.
  10. Тонелли М., Риелло М. Хроническая болезнь почек и старение популяции. Клин. нефрол. 2014;1:4–7.
  11. Akolekar D., Forsythe J.L., Oniscu G.C. Impact of patient characteristics and comorbidity profile on activation of patients on kidney transplantation waiting list. Transp. Proc. 2013;45(6):2115–22.
  12. Keddis M., Bhutani G., El-Zoghby ZM1. Cardiovascular disease burden and risk factors before and after kidney transplantation. Cardiovasc. Hematol. Disord. Drag. Turgets. 2014;14(3):185–94.
  13. Perivan R.L., Rao P.S. Quality of life of older patients undergoing renal transplantation finding the right immunosuppressive treatment. Drags Agung. 2014;31(2):103–9.


About the Autors


Information about the authors:
Vatazin A.V. –Prof., Head of Department of Transplantology, Nephrology and Artificial Organs of FAMS of SBIH MR “MRRCI n.a. M.F. Vladimirskiy”, Ph.D.
Shherbakova E.O. – ассистент of Department of Transplantology, Nephrology and Artificial Organs of FAMS of SBIH MR “MRRCI n.a. M.F. Vladimirskiy”, Ph.D.
E-mail: eottovna@yandex.ru
Prokopenko E.I. – профессор of Department of Transplantology, Nephrology and Artificial Organs of FAMS of SBIH MR “MRRCI n.a. M.F. Vladimirskiy”, Ph.D.
Stepanov V.A. – Senior Research Fellow of Department of Organ Donation of SBIH MR “MRRCI n.a. M.F. Vladimirskiy”, Ph.D.


Бионика Медиа